» Articles » PMID: 36074175

The Impact of Obesity on the Fibrostenosis Progression of Eosinophilic Esophagitis in a U.S. Veterans Cohort

Overview
Journal Dysphagia
Date 2022 Sep 8
PMID 36074175
Authors
Affiliations
Soon will be listed here.
Abstract

Whether obesity is protective against progression of EoE is unknown. The aim of this study was to assess factors that alter the progression of EoE and determine if BMI is correlated with reduced disease severity. In this retrospective analysis of the Department of Veterans Affairs electronic health records, patients with EoE who received at least one dilation were identified using ICD and CPT codes. Kaplan-Meier curves determined the relationship between BMI and time to second esophageal dilation as a measurement of severity of disease. Cox proportional hazards models assessed the risk of second dilation adjusted for potential confounders. Of 2890 patients with EoE and at least one dilation, 40% were obese (n = 1165). There were no clinically significant differences in demographics between obese and non-obese patients. Non-obese patients were more likely to be smokers and had a higher mean average of the number of dilation visits compared to obese patients (p < 0.05). When stratified by obesity, non-obese individuals had a median time to next dilation of 6.53 years (95% CI (5.83, 7.79)) compared to 9.24 years for obese individuals (95% CI (7.40, 15.04)). When stratified by six BMI categories, median time to second dilation increased with increasing BMI. The hazard ratio of second dilation for obese individuals was 0.81 (95% CI (0.72-0.92)). EoE patients with a higher BMI were less likely to undergo a second dilation compared to those with a lower BMI. Obesity may have a protective role in EoE or severe strictures may lead to malnourishment. Further research into these possibilities is needed.

Citing Articles

Association of Shift Work, Sociodemographic Variables and Healthy Habits with Obesity Scales.

Tosoratto J, Tarraga Lopez P, Lopez-Gonzalez A, Vallejos D, Martinez-Almoyna Rifa E, Ramirez-Manent J Life (Basel). 2024; 14(11).

PMID: 39598301 PMC: 11595592. DOI: 10.3390/life14111503.


Long-term prognosis and its associated predictive factors in patients with eosinophilic gastroenteritis.

Li K, Ruan G, Liu S, Xu T, Ma Y, Zhou W World J Gastroenterol. 2024; 30(2):146-157.

PMID: 38312116 PMC: 10835522. DOI: 10.3748/wjg.v30.i2.146.


Development and Validation of the Veterans Affairs Eosinophilic Esophagitis Cohort.

Low E, Song Q, Yadlapati R, Dellon E, Aceves S, Liu L Clin Gastroenterol Hepatol. 2023; 21(12):3030-3040.e4.

PMID: 37031716 PMC: 10558623. DOI: 10.1016/j.cgh.2023.03.033.

References
1.
Liacouras C, Furuta G, Hirano I, Atkins D, Attwood S, Bonis P . Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128(1):3-20.e6. DOI: 10.1016/j.jaci.2011.02.040. View

2.
Dellon E, Gonsalves N, Hirano I, Furuta G, Liacouras C, Katzka D . ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013; 108(5):679-92. DOI: 10.1038/ajg.2013.71. View

3.
Hirano I, Aceves S . Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin North Am. 2014; 43(2):297-316. PMC: 4127387. DOI: 10.1016/j.gtc.2014.02.015. View

4.
Furuta G, Katzka D . Eosinophilic Esophagitis. N Engl J Med. 2015; 373(17):1640-8. PMC: 4905697. DOI: 10.1056/NEJMra1502863. View

5.
Dellon E, Liacouras C, Molina-Infante J, Furuta G, Spergel J, Zevit N . Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018; 155(4):1022-1033.e10. PMC: 6174113. DOI: 10.1053/j.gastro.2018.07.009. View